PWA
TEVA icon

Physician Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Physician Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7K Buy
316
+34
+12% +$1.13K ﹤0.01% 857
2026
Q1 		$8.49K Hold
282
– – ﹤0.01% 847
2025
Q4 		$8.8K Buy
282
+18
+7% +$443 ﹤0.01% 816
2025
Q3 		$5.33K Buy
264
+31
+13% +$544 ﹤0.01% 907
2025
Q2 		$3.91K Buy
233
+33
+17% +$533 ﹤0.01% 863
2025
Q1 		$3.07K Sell
200
-36
-15% -$643 ﹤0.01% 806
2024
Q4 		$5.2K Buy
+236
New +$4.29K ﹤0.01% 731

Other funds holding TEVA

HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Physician Wealth Advisors's TEVA Position: Q2 2026 in Review

Physician Wealth Advisors increased its Teva Pharmaceuticals (TEVA) stake by 12% in Q2 2026, buying an estimated $1.13K and bringing the position to 316 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #857.

Physician Wealth Advisors first reported a position in TEVA in Q4 2024 and has held it in 7 quarters since. 246 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Physician Wealth Advisors held 316 shares of Teva Pharmaceuticals worth $10.7K as of Q2 2026.
  • Physician Wealth Advisors bought 34 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.13K.
  • Teva Pharmaceuticals made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #857 holding.
  • Physician Wealth Advisors first reported a position in Teva Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 246 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.